Scientists at the National Institute of Neurological Disorders and Stroke (NINDS) seek patients with cervical or focal hand dystonia who are receiving botulinum toxin injections for a study of a medication called amlodipine. This study will examine whether amlodipine can improve the effect of botulinum toxin injections for this movement disorder, which causes abnormal postures and disrupted movements.
The study will be conducted at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. All study-related expenses will be paid by the NIH.
For more information, physicians should contact Dr. Barbara Karp, Office of the Clinical Director, NINDS, NIH, Building 10, Room 5S209, 10 Center Drive MSC 1428, Bethesda, MD 20892-1438; telephone: 301-496-0150; fax: 301-480-2973.